InControl Medical Introduces Attain at CES 2019: The Most Effective, Non-Invasive Option Available for the Treatment of Urinary and/or Fecal Incontinence in Men and Women in a Single, At-Home Device

BROOKFIELD, Wis.–(BUSINESS WIRE)–InControl
Medical is proud to announce that Attain, the most advanced
over-the-counter device available to treat male and female incontinence
and the logical first choice for treatment, will be shown at the 2019
Consumer Electronics Show (CES, January 8-11, Las Vegas Sands,
Halls A-D – 43569).

According to Herschel “Buzz” Peddicord, InControl’s founder and CEO,
“This revolutionary medical device is designed to help treat the
approximately 87 million people in the U.S. suffering with stress, urge,
or mixed urinary incontinence, and/or bowel incontinence. Attain
provides muscle stimulation, visual biofeedback, and a guided exercise
program to solve incontinence at the source — the muscle level. Attain’s
regular self-treatment program, in the privacy of one’s home, eliminates
the need for pads, meds, surgery or diapers.”

Numerous
scientific studies and clinical
reviews have found pelvic floor electrical stimulation to be both
safe and effective for treating stress, urge, and mixed urinary and
fecal incontinence. Attain combines the proven methods of electrical
muscle stimulation with visual biofeedback, which studies have shown is
more effective than biofeedback alone.

• Muscle Stimulation: Attain delivers stimulation at specific
  frequencies in an alternating manner to increase pelvic floor muscle
  strength, calming the detrusor muscle. Attain elicits a full, deep
  muscle contraction of the pelvic floor, providing neuromuscular
  re-training.
• Visual Biofeedback: Attain provides a lighted biofeedback
  graph, which encourages users to contract their pelvic floor muscles
  slowly, maintain the lights, and then release at the end of the
  contraction timer. Visual cues are provided to guide the user through
  a series of variable timed, volitional contractions along with a
  relaxation phase similar to a physical therapy session.
• Customizable Probe: When inflated to “comfortably snug,” the
  Attain stimulation contacts are in full contact with the vaginal or
  rectal wall, ensuring a deep muscle contraction and comfortable,
  effective delivery of stimulation. The probe provides active
  resistance for pelvic floor muscles to contract against, resulting in
  a full muscle contraction, and it repositions musculature into a
  resting position between contractions, avoiding concerns for tonic
  contraction.

“We’ve been treating incontinence in women since 2012 with FDA-cleared
InTone, Apex, and ApexM,” adds Peddicord. “These products help women
strengthen pelvic floor muscles that have weakened or lost tone due to
aging or post-partum, often leading to bladder leakage, pelvic organ
prolapse, and difficulty or inability to orgasm. Because ApexM has been
so successful in treating urinary incontinence in more than 100,000
women, with exceptional
results, we are proud to now offer Attain, a more compact OTC device
with additional features, that works to treat all types of incontinence
for both men and women.”

FDA clearance for Attain is currently pending.

InControl representatives will be available at the company’s booth
for interviews and to explain how Attain works and what makes it the
most advanced device of its kind.

InControl Medical, LLC is a pelvic health company focusing on urinary
and fecal incontinence. The company’s philosophy is that a first-line
treatment should focus on improving the strength and support of the
pelvic floor – and thus restore continence naturally. Having sold in
excess of 100,000 pelvic floor devices, InControl Medical is so
confident in the effectiveness of its products, the company offers a
Performance Guarantee.

Contacts

Dara Shlifka
646-964-4446
dara@gcomworks.com